Warfarin

وارفارین

⚠ Unverified

🩸 Blood And Blood Forming OrgansVitamin K antagonist

Market / country: 🇺🇸 USA

Coumadin (US) · Jantoven (US)

🧮 Dose calculator

Atrial fibrillation / anticoagulation · Regimen source: FDA Warfarin · 2.3FDA Warfarin · 2

⛔ Individualised, INR-guided. If genotype unknown, usual start 2–5 mg once daily; non-valvular AF: target INR 2.5 (2.0–3.0). FDA Warfarin · 2.3FDA Warfarin · 2

🛡️ Safety & information

Contraindications

  • ⛔ Pregnancy (except high-risk mechanical valves); haemorrhagic tendencies or blood dyscrasias; recent or planned CNS or eye surgery (and other items in section 4). FDA Warfarin · 4

Formulations

👥 Special populations

  • 🤰 PregnancyContraindicated

    Label: contraindicated in pregnancy. FDA Warfarin · 4

    “Warfarin sodium tablets, USP are contraindicated in: • Pregnancy Warfarin sodium tablets, USP are contraindicated in women who are pregnant except in pregnant women with mechanical heart valves, who are at high risk of thromboembolism [see Warnings and Precautions (5.7) and Use in Specific Populations (8.1) ].”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Warfarin · 8.2

    “Risk Summary Warfarin was not present in human milk from mothers treated with warfarin from a limited published study.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Warfarin · 8.4

    “Adequate and well-controlled studies with warfarin sodium have not been conducted in any pediatric population, and the optimum dosing, safety, and efficacy in pediatric patients is unknown.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Warfarin · 8.5

    “Conduct more frequent monitoring for bleeding with administration of warfarin sodium to elderly patients in any situation or with any physical condition where added risk of hemorrhage is present.”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Warfarin · 8.3

    “Contraception Females Advise females of reproductive potential to use effective contraception during treatment and for at least 1 month after the final dose of warfarin sodium.”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav